Associated Papers
Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment.
Ihle MA et al.
Plos One, 2018
29451912 (PubMed )
Supplement: pone.0193048.s003.xls › Sanger_results
Select a paper to view details